Showing results (51-60 of 173) with videos related to
Sort By:
Pageof 18
BMC Cancer|November 14, 2018
Reduced RBM3 expression is associated with aggressive tumor features in esophageal cancer but not significantly linked to patient outcomeKatharina Grupp, Bianca Hofmann, Asad Kutup, et al.Plos One|June 2, 2015
Loss of SOX9 Expression Is Associated with PSA Recurrence in ERG-Positive and PTEN Deleted Prostate CancersChristoph Burdelski, Erzen Bujupi, Maria Christina Tsourlakis, et al.Oncotarget|March 13, 2015
Overexpression of thymidylate synthase (TYMS) is associated with aggressive tumor features and early PSA recurrence in prostate cancerChristoph Burdelski, Christian Strauss, Maria Christina Tsourlakis, et al.BMC Cancer|November 23, 2020
Hepatocellular carcinoma: Intratumoral EpCAM-positive cancer stem cell heterogeneity identifies high-risk tumor subtypeJenny Krause, Johann von Felden, Christian Casar, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 17, 2023
Noninferiority of Artificial Intelligence-Assisted Analysis of Ki-67 and Estrogen/Progesterone Receptor in Breast Cancer Routine DiagnosticsNiklas Abele, Katharina Tiemann, Till Krech, et al.Oncology Reports|July 3, 2015
Expression of DNA ligase IV is linked to poor prognosis and characterizes a subset of prostate cancers harboring TMPRSS2:ERG fusion and PTEN deletionKatharina Grupp, Laura Roettger, Martina Kluth, et al.Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 23, 2016
p16 upregulation is linked to poor prognosis in ERG negative prostate cancerChristoph Burdelski, Tatsiana Dieckmann, Asmus Heumann, et al.Journal of Hepatology|November 16, 2020
IL-17A/F enable cholangiocytes to restrict T cell-driven experimental cholangitis by upregulating PD-L1 expressionStephanie Stein, Lara Henze, Tobias Poch, et al.The Prostate|January 15, 2016
Cytoplasmic accumulation of ELAVL1 is an independent predictor of biochemical recurrence associated with genomic instability in prostate cancerNathaniel Melling, Berivan Taskin, Claudia Hube-Magg, et al.Plos One|August 1, 2015
High-Level HOOK3 Expression Is an Independent Predictor of Poor Prognosis Associated with Genomic Instability in Prostate CancerNathaniel Melling, Levon Harutyunyan, Claudia Hube-Magg, et al.Pageof 18